14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
RAY vs VIOT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAY vs VIOT. Trailing 12-month operating profitability (RAY 12.7% vs VIOT -2.4%) and valuation multiples (RAY N/M vs VIOT 7.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Furnishings, Fixtures & Appliances value chain with $84.4M market capitalization and -2.4% operating margin.
OpEx & R&D Reinvestment26.2% of Rev ($443M)
90D Engineering Disclosures0 Published
Investor FAQ RAY vs VIOT Key Questions & Quantitative Answers
As of Nov 20, 2026, Raytech Holding Limited (RAY) is the stronger overall head-to-head candidate over Viomi Technology Co., Ltd (VIOT) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RAY carries a Unified Composite Score of 63.4/100 (BUY) at $2.80 (N/M Forward P/E, 12.7% operating margin), whereas VIOT carries 50.8/100 (HOLD) at $1.25 (7.3x Forward P/E, -2.4% operating margin). Technically, RAY sits in a Neutral phase (RSI 51.3, UNCLASSIFIED options structure) and VIOT sits in a Neutral phase (RSI 40.6, UNCLASSIFIED options structure).
RAY leads the Growth & Scale pillar: RAY posts +196.0% YoY revenue growth and +33.5% YoY earnings growth on $46M TTM revenue (27.8% gross margin, 12.7% operating margin), compared with VIOT at -49.9% YoY revenue growth and -62.3% YoY earnings growth on $1.69B TTM revenue (23.8% gross margin, -2.4% operating margin). On trailing 12-month operating scale, RAY generates $46M in USD-normalized revenue versus $1.69B for VIOT. In operating R&D and SG&A reinvestment, RAY deploys 15.1% of Rev ($7.0M) (0 90-day corporate R&D disclosures) versus 26.2% of Rev ($443M) (0 disclosures) for VIOT.
VIOT screens cheaper on headline valuation multiples. RAY trades at N/M Forward P/E, 2.8x Trailing P/E, N/M PEG, and 0.3x EV/Revenue (12.8% EBITDA margin), whereas VIOT trades at 7.3x Forward P/E, 7.3x Trailing P/E, 0.73x PEG, and N/M EV/Revenue (0.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RAY (16.2% ROE) versus VIOT (-0.4% ROE) capital efficiency.
In options market volatility and institutional positioning, RAY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.24β · 50% Vol realized risk). By comparison, VIOT carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.51β · 61% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.